Genomic rearrangement of the capsule operon in a phylogenetically distinct cluster of the multi-drug-resistant Escherichia coli lineage ST131
mSphere · 03.11.2026
DOI: 10.1128/msphere.00673-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift mSphere, online erschienen am 03.11.2026. Verfasst von Isabelle Potterill und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Microbiology and Infection, School of Infection, Inflammation, and Immunology, College of Medicine and Health, University of Birmingham,…. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council.
Abstract (Originalsprache)
Escherichia coli ST131 is a dominant cause of multi-drug-resistant extraintestinal infections in humans. The lineage has a three-clade phylogenetic structure, of which clade C has gained resistance to multiple classes of antibiotics and is globally disseminated. As well as antimicrobial resistance, a number of virulence factors contribute to the success of ST131 clade C, including the production of capsule. Previous work on a limited number of strains has shown that the capsule operon in ST131 is highly variable. In this study, we analyzed the capsule genetics of E. coli ST131 by interrogating 3,033 genomes. Our data show a clonal distribution of capsule types and identify a monophyletic group of ST131 clade C strains that are characterized by an atypical capsule operon with highly divergent alleles of the key kpsM and kpsT genes. Our analysis suggests there is ongoing evolution within clade C of ST131, which looks to be driven not by the continuing evolution of antimicrobial resistance but by host-pathogen interactions. IMPORTANCE Multi-drug-resistant (MDR) Escherichia coli is a problematic cause of invasive disease in humans and animals. Resistance to multiple classes of antibiotics is severely limiting treatment options. ST131-C is a highly successful, MDR clone of E. coli that is a major cause of extraintestinal infections. Capsule is a key virulence factor in contributing to this clone's success, with capsule switching allowing the bacteria flexibility to thrive in different niches. We present evidence that suggests continual evolution of this proliferant clone influenced by host-pathogen interaction. Small genetic changes can define the success of a clone; therefore, it is important to monitor this continual evolution in pathogens.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Microbiology and Infection, School of Infection, Inflammation, and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom.
- Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
- School of Life and Environmental Sciences, Faculty of Science, University of Sydney, Sydney, Australia.
- Ineos Oxford Institute, Department of Biology, Life and Mind Building, University of Oxford, Oxford, United Kingdom.
ORCID-Profile: Alan McNally
Förderung
- Biotechnology and Biological Sciences Research Council
Zitieren
APA
Potterill, I., Hall, R. J., Moran, R. A., Cummins, E. A., & McNally, A. (2026). Genomic rearrangement of the capsule operon in a phylogenetically distinct cluster of the multi-drug-resistant Escherichia coli lineage ST131. mSphere. https://doi.org/10.1128/msphere.00673-26
Vancouver
Potterill I, Hall RJ, Moran RA, Cummins EA, McNally A. Genomic rearrangement of the capsule operon in a phylogenetically distinct cluster of the multi-drug-resistant Escherichia coli lineage ST131. mSphere. 2026. doi:10.1128/msphere.00673-26
BibTeX
@article{Potterill2026,
author = {Potterill, Isabelle and Hall, Rebecca J and Moran, Robert A and Cummins, Elizabeth A and McNally, Alan},
title = {Genomic rearrangement of the capsule operon in a phylogenetically distinct cluster of the multi-drug-resistant Escherichia coli lineage ST131},
journal = {mSphere},
year = {2026},
doi = {10.1128/msphere.00673-26}
}
EUVIMED